Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Alzheimer’s
The Jalisco Gene: A Military Pilot’s Story
Amyloid Hypothesis Twist: Restoring ‘Good’ Beta-Amyloid to Treat Alzheimer’s
Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow
FDA Limits the Use of Aduhelm After Criticisms of Broad Approval
Lynn Casteel Harper: Suffering No More—Reimagining Dementia for a Post-COVID World
A Virtual Microscope for Alzheimer’s Earns FDA ‘Breakthrough’ Designation
The Questions Doctors Are Getting About Aduhelm Right Now—And Their Answers
Neuroscientist Lisa Genova: How to Spot — and Prevent — Memory Loss
Will Insurance Companies and Medicare Cover Aduhelm’s High Price Tag?
A Retired Neurologist’s on His Own Alzheimer’s Journey
A Retired Neurologist On His Experience With Aduhelm’s Side Effects
Trial and Lots of Error: Experts Say Alzheimer’s Clinical Trials Need a Rethink
Olympic Gold Medalist Imran Sherwani Reveals Early-Onset Alzheimer’s Diagnosis
Amyloid Hypothesis in the Hot Seat After Aduhelm Approved for Alzheimer’s
What is an Aduhelm Infusion, and Why Was Its Approval So Controversial?
Previous
21
22
23
Next
Page load link
Go to Top